Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Journey Medical (DERM) EPS (Weighted Average and Diluted): 2020-2024

Historic EPS (Weighted Average and Diluted) for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to -$0.72.

  • Journey Medical's EPS (Weighted Average and Diluted) rose 25.00% to -$0.09 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.35, marking a year-over-year increase of 62.77%. This contributed to the annual value of -$0.72 for FY2024, which is 242.86% down from last year.
  • As of FY2024, Journey Medical's EPS (Weighted Average and Diluted) stood at -$0.72, which was down 242.86% from -$0.21 recorded in FY2023.
  • In the past 5 years, Journey Medical's EPS (Weighted Average and Diluted) registered a high of $0.49 during FY2020, and its lowest value of -$4.32 during FY2021.
  • Over the past 3 years, Journey Medical's median EPS (Weighted Average and Diluted) value was -$0.72 (recorded in 2024), while the average stood at -$0.87.
  • In the last 5 years, Journey Medical's EPS (Weighted Average and Diluted) plummeted by 981.63% in 2021 and then skyrocketed by 87.57% in 2023.
  • Over the past 5 years, Journey Medical's EPS (Weighted Average and Diluted) (Yearly) stood at $0.49 in 2020, then slumped by 981.63% to -$4.32 in 2021, then soared by 60.88% to -$1.69 in 2022, then skyrocketed by 87.57% to -$0.21 in 2023, then tumbled by 242.86% to -$0.72 in 2024.